Kristine M Ball sold $1.9M of ORKA stock

Kristine M Ball, Dir of Oruka Therapeutics, Inc. (ORKA), sold 18,000 shares of ORKA stock worth $1.9M, per an SEC Form 4 filed Nov 14, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 12, 2026, 2 days before it was made public.

ORKA has moved +0.3% since the trade date, from $104.99 to $105.35 (Nov 13, 2026 close).